Πέμπτη 20 Φεβρουαρίου 2020

Hearing Loss After Radiotherapy and Cisplatin Chemotherapy in Patients With Head and Neck Cancer

Hearing Loss After Radiotherapy and Cisplatin Chemotherapy in Patients With Head and Neck Cancer: This cohort study develops a hearing loss prediction model for patients with head and neck cancer after radiotherapy and/or cisplatin chemotherapy.


Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου